Improved photostability, reduced skin permeation and irritation of isotretinoin by solid lipid nanoparticles

Acta Pharmaceutica

Volumn 62, Issue 4, 2012, Pages 547-562

  Shiva, Golmohammadzadeh ^a   Somaye, Mortezania ^a   Mahmoud Reza, Jaafari ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Isotretinoin; Photostability; Skin irritation; Skin permeation; SLN

Indexed keywords

GLYCEROL STEARATE; ISOTRETINOIN; POLYSORBATE 80; SOLID LIPID NANOPARTICLE;

ADULT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG PENETRATION; DRUG STABILITY; DRUG TOLERABILITY; ENCAPSULATION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PHOTODEGRADATION; RABBIT; STRATUM CORNEUM; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 84876567745     PISSN: 13300075     EISSN: 18469558     Source Type: Journal    
DOI: 10.2478/v10007-012-0032-z     Document Type: Article

References (41)

1. A. R. Shalita, W. J. Cunningham, J. J. Leyden, P. E. Pochi and J. S. Strauss, Isotretinoin treatment of acne and disorders: An update, J. Am. Acad. Dermatol. 9 (1983) 629-638. DOI: 10.1016/S0190-9622(83)70176-3. (Pubitemid 13007761)
2. F. L. Meyskens, G. E. Goodman and D. S. Alberts, 13-Cis-retinoic acid: pharmacology, toxicology, and clinical applications for the prevention and treatment of human cancer, Crit. Rev. Oncol. Hematol. 3 (1985) 75-101; DOI: 10.1016/S1040-8428(85)80040-8.
3. J. Liu, W. Hu, H. Chen, Q. Ni, H. Xu and X. Yang, Isotretinoin-loaded solid lipid nanoparticles nanoparticles with skin targeting for topical delivery, Int. J. Pharm. 328 (2007) 191-195; DOI: 10. 1016/j.ijpharm.2006.08. 007. (Pubitemid 44880576)
4. S. Yang, J. Zhu, Y. Lu, B. Liang and C. Yang, Body distribution of camptothecin solid lipid nanoparticles after oral administration, Pharm. Res. 16 (1999) 751-757. (Pubitemid 29227107)
5. V. Jenning, A. Gysler, M. Schafer-Korting and S. H. Gohla. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin, Eur. J. Pharm. Biopharm. 49 (2000) 211-218. (Pubitemid 30229868)
6. R. H. Müller, M. Radtke and S. A Wissing, Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations, Adv. Drug Deliv. Rev. 54 (2002) S131-S155; DOI: 10.1016/S0169-409X(02)00118-7. (Pubitemid 35379959)
7. P. Ahlin, J. Kristl, S. Pecar, J. [trancar and M. [entjurc, The effect of lipophilicity of spin-labeled compounds on their distribution in solid lipid nanoparticles dispersions studied by electron paramagnetic resonance, J. Pharm. Sci. 92 (2003) 58-66; DOI: 10.1002/jps.10277. (Pubitemid 36042297)
8. V. P. Torchilin, Nanoparticle as Drug Carriers, Imperial College Press, London, 2006, pp. 187-205.
9. R. H. Müller, K. Mäder and S. Gohla, Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art, Eur. J. Pharm. Biopharm. 50 (2000) 161-177; DOI: 10.1016/S0939-6411(00)00087-4. (Pubitemid 30326695)
10. S. A. Wissing and R. H. Müller, The influence of solid lipid nanoparticles on skin hydration and viscoelasticity-in vivo study, Eur. J. Pharm. Biopharm. 56 (2003) 67-72; DOI: 10.1016/S0939-6411 (03)00040-7. (Pubitemid 36802049)
11. S. A. Wissing and R. H. Müller, Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration, J. Control. Release 81 (2002) 225-233. (Pubitemid 34607144)
12. R. Sivaramakrishnan, C. Nakamura, W. Mehnert, H. C. Korting, K. D. Kramer and M. Schafer-Korting. Glucocorticoid entrapment into lipid carriers-characterisation by parelectric spectroscopy and influence on dermal uptake, J. Control. Release 97 (2004) 493-502; DOI: 10.1016/j.jconrel.2004.04. 001. (Pubitemid 38802951)
13. E. B. Souto and R. H. Müller, The use of SLN and NLC as topical particulate carriers for imidazole antifungal agents, Pharmazie 61 (2006) 431-437. (Pubitemid 43724420)
14. P. Ahlin, J. Kristl and J. [mid-Kobar, Optimization of procedure parameters and physical stability of solid lipid nanoparticles in dispersions, Acta Pharm. 48 (1998) 257-267.
15. V. Jenning and S. H. Gohla, Encapsulation of retinoids in solid lipid nanoparticles (SLN). J. Microencapsul. 18 (2001) 149-158. (Pubitemid 32177833)
16. S. D. Mandawgade and V. B. Patravale. Development of SLNs from natural lipids: application to topical delivery of tretinoin, Int. J. Pharm. 363 (2008) 132-138; DOI: 10.1016/j.ijpharm.2008. 06.028.
17. M. Joshi and V. Patravale, Formulation and evaluation of nanostructured lipid carrier (NLC)-based gel of valdecoxib, Drug Dev. Ind. Pharm. 32 (2006) 911-918. (Pubitemid 44359752)
18. United States Pharmacopoeia 30, National Formulary 25, The United States Pharmacopoeial Convention, 2007, p.p. 2479, 2008.
19. K. A. Shah, A. A. Date, M. D. Joshi and V. B. Patravale, Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery, Int. J. Pharm. 345 (2007) 163-171; DOI: 10.1016/j.ijpharm. 2007.05.061. (Pubitemid 350087549)
20. G. Ioele, E. Cione, A. Risoli, G. Genchi and G. Ragno, Accelerated photostability study of tretinoin and isotretinoin in liposome formulations, Int. J. Pharm. 293 (2005) 251-260. DOI: 10.1016/j.ijpharm.2005.01.012. (Pubitemid 40381097)
21. S. Wissing and R. Müller, The influence of the crystallinity of lipid nanoparticles on their occlusive properties, Int. J. Pharm. 242 (2002) 377-379.
22. E. B. Souto, S. A. Wissing, C. M. Barbosa and R. H. Müller, Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery, Int. J. Pharm. 278 (2004) 71-77; DOI: 10.1016/j.ijpharm.2004.02.032. (Pubitemid 38670438)
23. J. Draize, G.Woodard and H. Calvery, Methods for the study of irritation and toxicity of substances topically applied to skin and mucous membranes, J. Pharmacol Exp. Ther. 82 (1944) 377-390.
24. K. F. Brain, K. A. Walters and A. C. Watkinson, Dermatological and Transdermal Formulation, Marcel Dekker Inc., New York 2002.
25. M. R. Jaafari, N. Bavarsad, B. S. Bazzaz, A. Samiei, D. Soroush and S. Ghorbani, Effect of topical liposomes containing paromomycin sulfate in the course of Leishmania major infection in susceptible BALB/c mice, Antimicrob. Agents Chemother. 53 (2009) 2259-2265.
26. H. Chen, X. Chang, D. Du, W. Liu, J. Liu, T. Weng, Y. Yang, H. XU and X. Yang, Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting, J. Control. Release 110 (2006) 296-306; DOI: 10.1016/j.jconrel.2005.09.052. (Pubitemid 41827483)
27. P. Treffel and B. Gabard. Skin penetration and sun protection factor of ultra-violet filters from two vehicles, Pharm. Res. 13 (1996) 770-774; DOI: 10.1023/A:1016012019483. (Pubitemid 26160098)
28. C. Couteau, N. Perez Cullel, A. E. Connan and L. J. Coiffard, Stripping method to quantify absorption of two sunscreens in human, Int. J. Pharm. 222 (2001) 153-157. (Pubitemid 32525796)
29. V. Sarveiya, S. Risk and H. A. Benson, Liquid chromatographic assay for common sunscreen agents: application to in vivo assessment of skin penetration and systemic absorption in human volunteers, J. Chromatogr B Analyt. Technol. Biomed. Life Sci. 803 (2004) 225-231; DOI: 10.1016/j. jchromb.2003.12.022. (Pubitemid 38452442)
30. S. Golmohammadzadeh, M. R. Jaafari and N. Khalili, Evaluation of liposomal and conventional formulations of octyl methoxycinnamate on human percutaneous absorption using the stripping method, J. Cosmet Sci. 59 (2008) 385-398; DOI: 10.1111/j.1468-2494.2009.00517-1.x.
31. D. Hou, C. Xie, K. Huang and C. Zhu, The production and characteristics of solid lipid nanoparticles (SLNs), Biomaterials 24 (2003) 1781-1785; DOI: 10.1016/S0142-9612(02)00578-1. (Pubitemid 36184733)
32. L. H. Reddy, K. Vivek, N. Bakshi and R. S. Murthy, Tamoxifen citrate loaded solid lipid nanoparticles (SLN): preparation, characterization, in vitro drug release, and pharmacokinetic evaluation, Pharm. Dev. Technol. 11 (2006) 167-177.
33. A. Saupe, S. A. Wissing, A. Lenk, C. Schmidt, R. H. Müller, Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC)-structural investigations on two different carrier systems, Biomed. Mater. Eng. 15 (2005) 393-402. (Pubitemid 41330513)
34. Z. Li, L. Yu, L. Zheng and F. Geng, Studies on crystallinity state of puerarin loaded solid lipid nanoparticles prepared by double emulsion method, J. Therm. Anal. Calorim. 99 (2010) 689-693. DOI: 10.1007/s10973-009-0127-z.
35. W. Mehnert and K. Mader, Solid lipid nanoparticles: production, characterization and applications, Adv. Drug Deliv. Rev. 47 (2001) 165-196. (Pubitemid 32324113)
36. Y. Yamaguchi, T. Nagasawa, N. M. Nakamura Takenaga, M. Mizoguchi, S. Kawai, Y. Mizushima and R. Igarashi, Successful treatment of photo-damaged skin of nano-scale atRA particles using a novel transdermal delivery, J. Control. Release 104 (2005) 29-40; DOI: 10.1016/j.jconrel.2004. 11.036. (Pubitemid 40615233)
37. Z. Mei, H. Chen, T. Weng, Y. Yang and X. Yang, Solid lipid nanoparticle and microemulsion for topical delivery of triptolide, Eur. J. Pharm. Biopharm. 56 (2003) 189-196; DOI: 10.1016/S0939-6411(03)00067-5. (Pubitemid 37072102)
38. C. Santos Maia, W. Mehnert, M. Schaller, H. C. Korting, A. Gysler, A. Haberland and M. Schäfer-Korting, Drug targeting by solid lipid nanoparticles for dermal use, J. Drug Target. 10 (2002) 489-495. (Pubitemid 35230199)
39. J. Stecova, W. Mehnert, T. Blaschke, B. Kleuser, R. Sivaramakrishnan, C. C. Zouboulis, H. Seltmann, H. C. Korting, K. D. Kramer and M. Schäfer-Korting, Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake, Pharm. Res. 24 (2007) 991-1000; DOI: 10.1007/s11095-006-9225-9. (Pubitemid 46675401)
40. D. D. Verma, S. Verma S, G. Blume and A. Fahr A, Particle size of liposomes influences dermal delivery of substances into skin, Int. J. Pharm. 258 (2003) 141-151; DOI: 10.1016/S0378-5173(03) 00183-2. (Pubitemid 36712878)
41. M. Sentjurc, K. Vrhovnik and J. Kristl, Liposomes as a topical delivery system: the role of size on transport studied by the EPR imaging method, J. Control. Release 59 (1999) 87-97; DOI: 10. 1016/S0168-3659(98)00181-3. (Pubitemid 29187196)